시장보고서
상품코드
1297133

세계의 의료용 IoT(IoMT) 시장 평가 : 컴포넌트별, 딜리버리 방식별, 제품 유형별, 용도별, 최종사용자별, 지역별, 기회, 예측(2016-2030년)

Internet of Medical Things Market Assessment, By Component, By Mode of Delivery, By Product, By Type, By Application, By End-user, By Region, Opportunities, and Forecast, 2016-2030F

발행일: | 리서치사: Market Xcel - Markets and Data | 페이지 정보: 영문 130 Pages | 배송안내 : 3-5일 (영업일 기준)


※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 의료용 IoT(IoMT) 시장 규모는 2022년 1,528억 7,000만 달러에서 2030년에 5,618억 2,000만 달러에 달하고, 2023-2030년 예측기간에 CAGR로 17.67%의 성장이 예측됩니다. 시장은 적극적인 환자 참여와 환자 중심 케어에 대한 주목 상승, 만성질환 발생률 증가에 의한 의료 시설 부담 증대, 모바일 컴퓨팅 디바이스 이용 확대 등의 중대한 요인에 의해 최근 큰 성장을 나타내고 있습니다.

세계의 의료용 IoT(IoMT) 시장에 대해 조사 분석했으며, 시장 규모와 예측, 시장 역학, 주요 기업 상황과 전망 등을 제공합니다.

목차

제1장 조사 방법

제2장 프로젝트 범위와 정의

제3장 세계의 의료용 IoT(IoMT) 시장에 대한 COVID-19의 영향

제4장 주요 요약

제5장 세계의 의료용 IoT(IoMT) 시장 전망(2016-2030년)

  • 시장 규모와 예측
    • 금액
    • 수량
  • 컴포넌트별
    • 하드웨어
    • 소프트웨어
    • 서비스
  • 딜리버리 방식별
    • 온프레미스
    • 클라우드
  • 제품별
    • 고정형 의료기기
    • 이식형 의료기기
    • 가동형 의료기기
    • 웨어러블 의료기기
    • 기타
  • 유형별
    • 바이탈 사인 모니터링 기기
    • 이식형 심장·호흡기 기기
    • 의료용 영상 기기
    • 마취 기기
    • 당뇨병 모니터링 기기
    • 원격 구급 케어 기기
    • 기타
  • 용도별
    • 원격의료
    • 투약 관리
    • 환자 모니터링
    • 기타
  • 최종사용자별
    • 병원
    • 진료소
    • 재택 케어
    • 연구·학술기관
    • 기타
  • 지역별
    • 북미
    • 남미
    • 유럽
    • 아시아태평양
    • 중동 및 아프리카
  • 시장 점유율 : 기업별(2022년)

제6장 세계의 의료용 IoT(IoMT) 시장 전망 : 지역별(2016-2030년)

  • 북미
    • 컴포넌트별
    • 딜리버리 방식별
    • 제품별
    • 유형별
    • 용도별
    • 최종사용자별
    • 미국
    • 캐나다
    • 멕시코
  • 유럽
    • 독일
    • 프랑스
    • 이탈리아
    • 영국
    • 러시아
    • 네덜란드
    • 스페인
    • 터키
    • 폴란드
  • 남미
    • 브라질
    • 아르헨티나
  • 아시아태평양
    • 인도
    • 중국
    • 일본
    • 호주
    • 베트남
    • 한국
    • 인도네시아
    • 필리핀
  • 중동 및 아프리카
    • 사우디아라비아
    • 아랍에미리트
    • 남아프리카공화국

제7장 시장 매핑(2022년)

  • 컴포넌트별
  • 딜리버리 방식별
  • 제품별
  • 유형별
  • 용도별
  • 최종사용자별
  • 지역별

제8장 거시적 환경과 업계 구조

  • 수급 분석
  • 수출입 분석
  • 밸류체인 분석
  • PESTEL 분석
  • Porter's Five Forces 분석

제9장 시장 역학

  • 성장 촉진요인
  • 성장 억제요인(과제, 억제요인)

제10장 규제 체계와 혁신

  • 임상시험
  • 특허 상황
  • 정부 규제
  • 혁신/신기술

제11장 주요 기업 상황

  • 시장 리더 상위 5개사 경쟁 매트릭스
  • 시장 리더 상위 5개사 시장 매출 분석(2022년)
  • 인수합병/합작투자(해당되는 경우)
  • SWOT 분석(시장 진출 기업 5개사용)
  • 특허 분석(해당되는 경우)

제12장 가격 분석

제13장 사례 연구

제14장 주요 기업 전망

  • Siemens Healthineers International AG
  • Medtronic Plc
  • Johnson & Johnson MedTech
  • Koninklijke Philips N.V.
  • Hill-rom Holdings, Inc.
  • Abbott Healthcare Pvt Ltd
  • IBM Corporation
  • Ypsomed MG
  • Boston Scientific Corporation
  • CISCO Systems
  • GE Healthcare
  • Dexcom, Inc.
  • Apple Inc.

제15장 전략적 추천사항

제16장 당사에 대해·면책사항

KSM 23.07.03

Global Internet of Medical Things (IoMT) Market size was valued at USD 152.87 billion in 2022 which is expected to reach USD 561.82 billion in 2030 with a CAGR of 17.67% for the forecast period between 2023 and 2030. IoMT is becoming increasingly popular due to its numerous advantages such as real-time patient monitoring, improved health outcomes, increased patient engagement and better chronic care management.IoT has accelerated the development of telemedicine, remote patient monitoring, interactive medicine, fitness & wellness assessment devices, and automation in healthcare institutions.

The global IoMT market has witnessed significant growth in recent years, driven by several key factors such as increasing focus on active patient engagement & patient-centric care, the rising burden on healthcare facilities with higher incidences of chronic health conditions, and greater usage of mobile computing devices.

For instance, IoMT devices are largely being recommended by doctors for finding the cause of gastrointestinal bleeding, diagnosing cancer, celiac disease, and so on. One such emerging trend is capsule endoscopy which is done via smart or digital pills for the areas which are not easily accessible through traditional endoscopy. Medtronic, Olympus Corporation, and CapsoVision are some of the organizations that manufacture and sell capsule endoscopy.

Additionally, with the help of smart bracelets and AI-synchronized cloud servers, patients now have access to individualized care with real-time monitoring. To automate these procedure s and implement effective safety regulations, sanitation and disinfection manufacturers had also launched UV-based mobile solutions. Medical device manufacturers are introducing AI-based IoT devices and machine learning solutions to promote improved detection and enhance treatment capabilities.

Digitization is Accelerating the Market Expansion

The healthcare industry has adopted digital technology to transition from mechanical and analogue electrical devices to existing digital technology. Digital technology is frequently used in the healthcare industry to monitor patient care quality, enhance clinical supp ort, and search medical information resources. Rapid digitization of healthcare systems has aided in effective patient care. Digitization helps in the improvement of treatment continuity, the promotion of good health, and illness prevention. The use of digital tools has the potential to improve the way health data is used in research and innovation, supporting more individualized treatment, superior health interventions, and improved health and wellness services.

The American Medical Association (AMA) reported that 85% of doctors in the United States acknowledged that telehealth improved the timeliness of care, and more than 70% of them were willing to increase the use of telehealth.

Increasing Demand for Real-Time Patient Health Monitoring

Internet of medical things (IoMT) connects the physical & digital world which tracks and adjusts patient behaviour in real-time to treat chronic illnesses such as- high blood pressure, diabete s, and asthma. Furthermore, IoMT technology can also improve the flow of information and various clinical processes by connecting people (patients, care givers and clinicians), patient or performance data, processes (care delivery and monitoring), and enablers (medical devices and mobile applications). With the help of this technology, patients can receive care at home, in ambulatory care facilities, or elsewhere not connected to a hospital. For instance, in June 2022, GYANT, the patient journey automation company, launched Asynchronous Care Platform to automate patient intake in EHR to making virtual visits more efficient and timesaving with minimal physical contact.

Government Regulations

In June 2022, the American Hospital Association introduced the Protecting and Transforming Cyber Healthcare (PATCH) Act, which represents nearly 5,000 healthcare delivery organizations and millions of healthcare professionals. Under the PATCH Act, device manufacturers would have to exhibit cybersecurity precautions to the FDA before going to the market; provide transparent software bill of materials (SBOM) for transparency and greater security insights into device software components and vulnerabilities; and provide timely device security information throughout their products' lifecycles. Depending on their level of cybersecurity maturity, most organisations should look at stricter governance to assess the risk of the new devices they plan to build and apply for FDA approval for to comply with the Patch Act's requirements and upcoming FDA requirements.

Wearable Medical Devices Will Grow at a Faster Rate

Wearable medical devices are becoming popular among patients of all age-groups. Even though they are among the most basic and innovative types of wearable technology, they are enduring because they easily connect with smartphone apps to provide users with priceless health and fitness tips. Companies are allocating a significantly higher percentage of their R&D budget to the development of wearable devices. Many new businesses are approaching the market with cutting-edge wea rables.

Smartwatches, which formerly served merely as timepieces and step counters, have evolved into clinically useful healthcare tools. For instance, in September 2022, Apple unveiled its latest smartwatch models. The Series 8 model is jam-packed with industry-leading health features, such as a temperature sensor that enables sophisticated functions for women's health and crash detection for car accidents. With a faster processor and longer battery life than its predecessor, the second-generation Apple Watch SE is a great Series 8 alternative for those looking for a budget friendly option.

Smart Pills Gradually Gaining Traction

Smart pills are the upcoming trend in remote patient monitoring and personalized medicine applications. Smart pills offer the ability to collect real-time data on medication adherence, vital signs, and other physiological parameters, allowing healthcare providers to monitor patients' health remotely and tailor treatment plans accordingly. This trend aligns with the broader shift towards telemedicine and digital health solutions, which aim to improve patient care, increase efficiency, and reduce healthcare costs. For instance, Proteus has developed an FDA-approved smart pill system that combines sensor-enabled medication with a wearable patch and a mobile app. Their system allows for remote monitoring of medication adherence and patient health data.

Remote Patient Monitoring Will Revolutionize Healthcare

Remote patient monitoring aims to decrease healthcare costs by decreasing the requisite for in-patient visits and hospital stays while maintaining timely and efficient care. It also improves patient outcomes by enabling healthcare professionals to identify and address health issues early, lowering the likelihood of complications. The remote patient monitoring segment is anticipated to expand due to the steadily increasing elderly population. Companies are focusing on bringing in new innovative products and monitoring devices that are more convenient for usage at home. For instance, in January 2022, Omron Healthcare launched VitalSight, a remote patient monitoring programme that enables patients to commit to routine heart health monitoring from the convenience of their homes.

World Health Organization (WHO) reports that the percent age of people aged 65 and older has increased from 6% in 1990 to 9% in 2019 and is expected to reach 16% in 2050. Nearly half of Americans are very supportive of integrating remote patient monitoring into medical care.

Impact of COVID-19

The sudden emergence of the COVID-19 virus had put the whole healthcare sector on high alert. It had compelled healthcare facilities, hospitals, and diagnostic centers worldwide to embrace the utilization of IoMT technology. The creation of a new "smart" healthcare system based on early detection, spreading control, education and medication has been supported by Internet of Medical Things and COVID-19, making living in the new norm easier. Patients with various health conditions were forced to use techno logy-driven approaches and remote care because traditional care facilities were closed or reserved for COVID-19 patients. Telehealth and IoT-enabled wearables were in high demand during the pandemic and helped in treating patients with serious illnesses.

Key Players Landscape and Outlook

Healthcare providers and technology companies are engaging in mergers and acquisitions, joint ventures, and extensive collaborations in the IoMT sector. IoMT applications are becoming more mainstream, which is creating new challenges and opportunities for businesses in the digital health sector and driving up merger and acquisition activity. For instance, Medtronic Plc. and Surgical Theater, Inc. have jointly developed StealthStation S8 , launched in June 2023, which is a surgical navigation system. The unique Stealth-Midas MR8™ high-speed drill, provides the ability to easily navigate Midas Rex™ tools with StealthStation™ navigation during spinal surgery.

Additionally, Healthcare companies like Philips and Medtronic, as well as technology giants such as Cisco Systems, Inc., IBM Corporation, Abbott Healthcare Pvt Ltd and Boston Scientific Corporation are all creating capabilities in IoMT segment.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Impact of Covid-19 on Global Internet of Medical Things Market

4. Executive Summary

5. Global Internet of Medical Things Market Outlook, 2016-2030F

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
    • 5.1.2. By Volume
  • 5.2. By Component
    • 5.2.1. Hardware
    • 5.2.2. Software
    • 5.2.3. Services
  • 5.3. By Mode of Delivery
    • 5.3.1. On-premises
    • 5.3.2. Cloud
  • 5.4. By Product
    • 5.4.1. Stationary Medical Devices
    • 5.4.2. Implanted Medical Devices
    • 5.4.3. Portable Medical Devices
    • 5.4.4. Wearable Medical Devices
      • 5.4.4.1. Medical Grade
      • 5.4.4.2. Consumer Grade
    • 5.4.5. Others
  • 5.5. By Type
    • 5.5.1. Vital Signs Monitoring Devices
    • 5.5.2. Implantable Cardiac
    • 5.5.3. Respiratory Devices
    • 5.5.4. Medical Imaging Devices
    • 5.5.5. Anaesthetic Devices
    • 5.5.6. Diabetes Monitoring Devices
    • 5.5.7. Remote Emergency Care Devices
    • 5.5.8. Others
  • 5.6. By Application
    • 5.6.1. Telemedicine
    • 5.6.2. Medication Management
    • 5.6.3. Patient Monitoring
    • 5.6.4. Others
  • 5.7. By End-user
    • 5.7.1. Hospitals
    • 5.7.2. Clinics
    • 5.7.3. Home Care
    • 5.7.4. Research & Academic Institutions
    • 5.7.5. Others
  • 5.8. By Region
    • 5.8.1. North America
    • 5.8.2. South America
    • 5.8.3. Europe
    • 5.8.4. Asia-Pacific
    • 5.8.5. Middle East and Africa
  • 5.9. By Company Market Share (%), 2022

6. Global Internet of Medical Things Market Outlook, By Region, 2016-2030F

  • 6.1. North America*
    • 6.1.1. By Component
      • 6.1.1.1. Hardware
      • 6.1.1.2. Software
      • 6.1.1.3. Services
    • 6.1.2. By Mode of Delivery
      • 6.1.2.1. On-premises
      • 6.1.2.2. Cloud
    • 6.1.3. By Product
      • 6.1.3.1. Stationary Medical Devices
      • 6.1.3.2. Implanted Medical Devices
      • 6.1.3.3. Portable Medical Devices
      • 6.1.3.4. Wearable Medical Devices
      • 6.1.3.4.1. Medical Grade
      • 6.1.3.4.2. Consumer Grade
      • 6.1.3.5. Others
    • 6.1.4. By Type
      • 6.1.4.1. Vital Signs Monitoring Devices
      • 6.1.4.2. Implantable Cardiac
      • 6.1.4.3. Respiratory Devices
      • 6.1.4.4. Medical Imaging Devices
      • 6.1.4.5. Anaesthetic Devices
      • 6.1.4.6. Diabetes Monitoring Devices
      • 6.1.4.7. Remote Emergency Care Devices
      • 6.1.4.8. Others
    • 6.1.5. By Application
      • 6.1.5.1. Telemedicine
      • 6.1.5.2. Medication Management
      • 6.1.5.3. Patient Monitoring
      • 6.1.5.4. Others
    • 6.1.6. By End-user
      • 6.1.6.1. Hospitals
      • 6.1.6.2. Clinics
      • 6.1.6.3. Home Care
      • 6.1.6.4. Research & Academic Institutions
      • 6.1.6.5. Others
    • 6.1.7. United States*
      • 6.1.7.1. By Component
      • 6.1.7.1.1. Hardware
      • 6.1.7.1.2. Software
      • 6.1.7.1.3. Services
      • 6.1.7.2. By Mode of Delivery
      • 6.1.7.2.1. On-premises
      • 6.1.7.2.2. Cloud
      • 6.1.7.3. By Product
      • 6.1.7.3.1. Stationary Medical Devices
      • 6.1.7.3.2. Implanted Medical Devices
      • 6.1.7.3.3. Portable Medical Devices
      • 6.1.7.3.4. Wearable Medical Devices
      • 6.1.7.3.4.1. Medical Grade
      • 6.1.7.3.4.2. Consumer Grade
      • 6.1.7.3.5. Others
      • 6.1.7.4. By Type
      • 6.1.7.4.1. Vital Signs Monitoring Devices
      • 6.1.7.4.2. Implantable Cardiac
      • 6.1.7.4.3. Respiratory Devices
      • 6.1.7.4.4. Medical Imaging Devices
      • 6.1.7.4.5. Anaesthetic Devices
      • 6.1.7.4.6. Diabetes Monitoring Devices
      • 6.1.7.4.7. Remote Emergency Care Devices
      • 6.1.7.4.8. Others
      • 6.1.7.5. By Application
      • 6.1.7.5.1. Telemedicine
      • 6.1.7.5.2. Medication Management
      • 6.1.7.5.3. Patient Monitoring
      • 6.1.7.5.4. Others
      • 6.1.7.6. By End-user
      • 6.1.7.6.1. Hospitals
      • 6.1.7.6.2. Clinics
      • 6.1.7.6.3. Home Care
      • 6.1.7.6.4. Research & Academic Institutions
      • 6.1.7.6.5. Others
    • 6.1.4. Canada
    • 6.1.5. Mexico

All segments will be provided for all regions and countries covered

  • 6.2. Europe
    • 6.2.1 Germany
    • 6.2.2 France
    • 6.2.3 Italy
    • 6.2.4 United Kingdom
    • 6.2.5 Russia
    • 6.2.6 Netherlands
    • 6.2.7 Spain
    • 6.2.8 Turkey
    • 6.2.9 Poland
  • 6.3. South America
    • 6.3.1. Brazil
    • 6.3.2. Argentina
  • 6.4. Asia-Pacific
    • 6.4.1. India
    • 6.4.2. China
    • 6.4.3. Japan
    • 6.4.4. Australia
    • 6.4.5. Vietnam
    • 6.4.6. South Korea
    • 6.4.7. Indonesia
    • 6.4.8. Philippines
  • 6.5. Middle East & Africa
    • 6.5.1. Saudi Arabia
    • 6.5.2. UAE
    • 6.5.3. South Africa

7. Market Mapping, 2022

  • 7.1. By Component
  • 7.2. By Mode of Delivery
  • 7.3. By Product
  • 7.4. By Types
  • 7.5. By Application
  • 7.6. By End-user
  • 7.7. By Region

8. Macro Environment and Industry Structure

  • 8.1. Supply Demand Analysis
  • 8.2. Import Export Analysis
  • 8.3. Value Chain Analysis
  • 8.4. PESTEL Analysis
    • 8.4.1. Political Factors
    • 8.4.2. Economic System
    • 8.4.3. Social Implications
    • 8.4.4. Technological Advancements
    • 8.4.5. Environmental Impacts
    • 8.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 8.5. Porter's Five Forces Analysis
    • 8.5.1. Supplier Power
    • 8.5.2. Buyer Power
    • 8.5.3. Substitution Threat
    • 8.5.4. Threat from New Entrant
    • 8.5.5. Competitive Rivalry

9. Market Dynamics

  • 9.1. Growth Drivers
  • 9.2. Growth Inhibitors (Challenges and Restraints)

10. Regulatory Framework and Innovation

  • 10.1. Clinical Trials
  • 10.2. Patent Landscape
  • 10.3. Government Regulations
  • 10.4. Innovations/Emerging Technologies

11. Key Players Landscape

  • 11.1. Competition Matrix of Top Five Market Leaders
  • 11.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2022)
  • 11.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 11.4. SWOT Analysis (For Five Market Players)
  • 11.5. Patent Analysis (If Applicable)

12. Pricing Analysis

13. Case Studies

14. Key Players Outlook

  • 14.1. Siemens Healthineers International AG
    • 14.1.1. Company Details
    • 14.1.2. Key Management Personnel
    • 14.1.3. Products & Services
    • 14.1.4. Financials (As reported)
    • 14.1.5. Key Market Focus & Geographical Presence
    • 14.1.6. Recent Developments
  • 14.2. Medtronic Plc
  • 14.3. Johnson & Johnson MedTech
  • 14.4. Koninklijke Philips N.V.
  • 14.5. Hill-rom Holdings, Inc.
  • 14.6. Abbott Healthcare Pvt Ltd
  • 14.7. IBM Corporation
  • 14.8. Ypsomed MG
  • 14.9. Boston Scientific Corporation
  • 14.10. CISCO Systems
  • 14.11. GE Healthcare
  • 14.12. Dexcom, Inc.
  • 14.13. Apple Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

15. Strategic Recommendations

16. About Us & Disclaimer

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제